Remove 2024 Remove Hospitals Remove Packaging
article thumbnail

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

Pharmacists can also provide diabetes management as an embedded member of clinic or hospital locations. May 15, 2024. Kirsty [package insert]. According to an article in Diabetes, Metabolic Syndrome and Obesity , the authors acknowledge how the role of the pharmacist has changed over the last 50 years. News release.

FDA 331
article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Find out more Introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), it will allow patients to receive personalised treatments made at their hospital, clinic or near their homes.

article thumbnail

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

On average, 58% of branded drugs approved between 2021 and 2024 in Europe have either fully or restricted reimbursement. First, the access landscape for 220 originator medicines approved by the EMA between 2021–2024 was assessed. Reimbursement status for each brand per European market was analysed during this period.

article thumbnail

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA 52
article thumbnail

Vutrisiran marks first silencer approved for ATTR-CM

Pharmaceutical Technology

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.